Exact Mass: 656.3129
Exact Mass Matches: 656.3129
Found 242 metabolites which its exact mass value is equals to given mass value 656.3129
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Bisinomenine
Disinomenine is a morphinane alkaloid. Disinomenine is a natural product found in Sinomenium acutum with data available.
Riboflavine 2',3',4',5'-tetrabutanoate
Riboflavine 2,3,4,5-tetrabutanoate is widely used food additiv Widely used food additive.
(2R)-2-[[(2R)-2-[[(2S)-2-(Azepane-1-carbonylamino)-4-methylpentanoyl]amino]-3-(1-formylindol-3-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoic acid
gaudichaudiic acid H
An organic heteroheptacyclic compound isolated from the bark of Indonesian Garcinia gaudichaudii and exhibits cytotoxic activity.
15-O-deacetylnimbolidin B
A tricyclic triterpenoid that is isolated from Melia azedarach and exhibits anticancer activity.
(5R*,7S*,8S*,9S*,10R*)-4-benzoyl-1-beta-D-glucopyranosyl-7alpha-acetoxycleroda-3,13-dien-15,16-olide-18-oate
12-(2-Methylbutanoyl),7-ketone,1,11-di-Ac,Me ester-1,3,7,11,12-Pentahydroxy-14-meliacen-28-oic acid
12-O-cinnamoyl-3beta,8beta,12beta,14beta,17beta,20-hexahydroxy-(20S)-pregn-5-enyl-3-O-beta-D-cymaropyranoside|gymnepregoside I|penupogenin 3-O-beta-D-cymaropyranoside
(2R*,3S*,6S*,7R*,8R*,9S*,13S*,15R*)-7,8,9,15-tetraacetoxy-3-benzoyloxy-6-hydroxy-14-oxojatropha-4E,11E-diene|rel-(2R,3S,4E,6S,7R,8R,9S,11E,13S,15R)-7,8,9,15-tetraacetoxy-3-(benzoyloxy)-6-hydroxy-14-oxojatropha-4,11-diene
12-(dodeca-2,4,6-trienoyl)-13-(2-methylbutanoyl)-6,7-epoxy-4,5,9,12,13,20-hexahydroxy-1-tigliaen-3-one|EBI-59
(2S,3S,4R,5R,6R,8R,12S,13S,14R,15K)-1,5,8,14-tetraacetoxy-3-benzoyloxy-l5-hydroxy-9-oxo-paraliane|Paraliane 12
12-deacetyloxy-12-(2-methylbutanoyloxy)turrapubin A|turrapubin C
PREGN-5-EN-20-ONE,3-[(6-O-B-D-GLUCOPYRANOSYL-B-D-GLUCOPYRANOSYL)OXY]-14-HYDROXY-,(3B,14B)- (9CI)
3-O-alpha-L-rhamnopyranosyl-1-O-sulfo-(25S)-ruscogenin
2alpha,3beta-dihydroxy-5alpha-pregn-16-en-20-one-3-O-beta-D-glucopyranosyl(1->4)-beta-D-galactopyranoside
1beta,5alpha,14alpha,17alpha-tetraacetoxy-3beta-benzoyloxy-15beta-hydroxy-9-oxoparaliane|1??,5??,14??,17??-Tetraacetoxy-3??-benzoyloxy-15??-hydroxy-9-oxoparaliane
2alpha,5alpha,14alpha,17alpha-tetraacetoxy-3beta-benzoyloxy-15beta-hydroxy-9-oxoparaliane|portlandicine
5,7-diacetoxy-3-benzoyloxy-14,15-dihydroxy-8-(2-methylbutyryloxy)-9-oxojatropha-6(17),11E-diene
5,6,14-triacetoxy-3-benzoyloxy-8,15-dihydroxy-9-oxojatropha-6(17),11E-diene
3,7,13,17-O-tetraacetyl-5-O-benzoyl-14-oxopremyrsinol
3,7,15,17-O-tetraacetyl-5-O-benzoyl-14-oxopremyrsinol
[1,3,12-triacetyloxy-17-(furan-3-yl)-4,4,8,10,13-pentamethyl-2,3,5,6,7,9,11,12,16,17-decahydro-1H-cyclopenta[a]phenanthren-7-yl] 2-hydroxy-3-methylbutanoate
C35H44O12_(1S,2S,3aR,4S,5R,6E,10R,11S,13R,13aR)-4,10,11,13-Tetraacetoxy-3a-hydroxy-2,5,8,8-tetramethyl-12-methylene-9-oxo-2,3,3a,4,5,8,9,10,11,12,13,13a-dodecahydro-1H-cyclopenta[12]annulen-1-yl benzoate
Glu His Trp Trp
Glu Trp His Trp
Glu Trp Trp His
His Glu Trp Trp
His Trp Glu Trp
His Trp Trp Glu
Arg Arg Tyr Tyr
Arg Tyr Arg Tyr
Arg Tyr Tyr Arg
Trp Glu His Trp
Trp Glu Trp His
Trp His Glu Trp
Trp His Trp Glu
Trp Trp Glu His
Trp Trp His Glu
Tyr Arg Arg Tyr
Tyr Arg Tyr Arg
Tyr Tyr Arg Arg
Hibon
Deferoxamine mesylate
D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Deferoxamine mesylate (Deferoxamine B mesylate) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine mesylate upregulates HIF-1α levels with good antioxidant activity. Deferoxamine mesylate also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine mesylate can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19[1][2][3][4][5].
1,4-Di[4-(6-acryloyloxyhexyloxy)benzoyloxy]-2-methylbenzene
(S)-Benzyl 2-((S)-4-methyl-2-((S)-2-(2-morpho lino acetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoate
coproporphyrinogen III(4-)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(2E,4S,5S,6R,7R,8R,9R,10R,11S,12R,13Z,15E)-5,7,9,11-tetrahydroxy-17-[(6-hydroxy-3,7-dimethyl-1,4-dioxo-5,8-dihydronaphthalen-2-yl)amino]-2,4,6,8,10,12,16-heptamethyl-17-oxoheptadeca-2,13,15-trienoate
N-{5-[acetyl(hydroxy)amino]pentyl}-N-(5-{4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanamido}pentyl)-N-hydroxybutanediamide methanesulfonate
D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(1-naphthalenyl)urea
Iron(3+) 2,5,13,16,24,27-hexaoxo-1,6,12,17,23,28-hexaazacyclotritriacontane-1,12,23-triolate
[1-Hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] pentadecanoate
[1-Heptanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] tetradecanoate
[1-Butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] heptadecanoate
[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-nonanoyloxypropan-2-yl] dodecanoate
[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-octanoyloxypropan-2-yl] tridecanoate
[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] octadecanoate
[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] hexadecanoate
[1-Decanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] undecanoate
[1,3,12-triacetyloxy-17-(furan-3-yl)-4,4,8,10,13-pentamethyl-2,3,5,6,7,9,11,12,16,17-decahydro-1H-cyclopenta[a]phenanthren-7-yl] 2-hydroxy-3-methylbutanoate
[1-Acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] nonadecanoate
[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate
[(2R)-2-decanoyloxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] undecanoate
[(2R)-1-decanoyloxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropan-2-yl] undecanoate
coproporphyrinogen III(4-)
Tetracarboxylate anion of coproporphyrinogen III.
coproporphyrinogen I(4-)
The cyclic tetrapyrrole anion formed by loss of a proton from each of the four carboxy groups of coproporphyrinogen I.
2-O-DMT-Sulfonyldiethanol phosphoramidite
2-O-DMT-Sulfonyldiethanol phosphoramidite is a phosphoramidite that can be used in the synthesis of oligonucleotides.
methyl (1r,2s,5s)-16-[(2z,6e)-3-[(acetyloxy)methyl]-7,11-dimethyldodeca-2,6,10-trien-1-yl]-10,14-dihydroxy-2-(prop-1-en-2-yl)-6,18-dioxapentacyclo[9.7.1.1¹,⁵.0⁷,¹⁹.0¹²,¹⁷]icosa-7(19),8,10,12,14,16-hexaene-5-carboxylate
2,4,9,15-tetrakis(acetyloxy)-11-hydroxy-10,14,17,17-tetramethyl-6-oxatetracyclo[11.3.1.0³,¹⁰.0⁴,⁷]heptadec-13-en-12-yl benzoate
[5,6,7,8,9-pentahydroxy-4,17-dimethyl-13-phenyl-15-(prop-1-en-2-yl)-12,14,18-trioxapentacyclo[11.4.1.0¹,¹⁰.0²,⁶.0¹¹,¹⁵]octadecan-8-yl]methyl dec-2-enoate
methyl 16-{3-[(acetyloxy)methyl]-7,11-dimethyldodeca-2,6,10-trien-1-yl}-10,14-dihydroxy-2-(prop-1-en-2-yl)-6,18-dioxapentacyclo[9.7.1.1¹,⁵.0⁷,¹⁹.0¹²,¹⁷]icosa-7(19),8,10,12,14,16-hexaene-5-carboxylate
n-[2-({[(1s,2r,3r,4s,6s,8r,9s,10s,13s,16s,17r,18s)-4-(acetyloxy)-11-ethyl-8,9-dihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methoxy}carbonyl)phenyl]ethanimidic acid
17,19-bis(acetyloxy)-4-methoxy-1,9,11,16-tetramethyl-8-(2-oxo-5h-furan-3-yl)-5,14-dioxapentacyclo[11.6.1.0²,¹¹.0⁶,¹⁰.0¹⁶,²⁰]icos-9-en-12-yl 2-methylbut-2-enoate
(1r,2r,4s,5s,6s,10r,11s,15r,16r,18s,19r)-4,18-bis(acetyloxy)-16-hydroxy-1,5,10,15-tetramethyl-6-(5-oxooxolan-3-yl)-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadec-8-en-11-yl (2e)-3,4-dimethylpent-2-enoate
(3as,3bs,4r,4as,5r,6r,7s,7ar,8r,8ar,9as)-4,5,8,9a-tetrakis(acetyloxy)-4a-hydroxy-2,2,3b,6,8a-pentamethyl-1-oxo-octahydro-3h-cyclopenta[a]s-indacen-7-yl benzoate
(2's,4as,7's,9s,10as)-6,15'-dihydroxy-7,13'-diisopropyl-1,1,2',4a,6',6'-hexamethyl-2,3,4,10a-tetrahydro-11'-oxaspiro[phenanthrene-9,10'-tetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadecane]-1'(15'),9'(16'),12'-triene-5,8,8',10,14'-pentone
[(1r,2r,4s,5s,6r,7s,8r,9s,10s,11r,13s,15r,17r)-5,6,7,8,9-pentahydroxy-4,17-dimethyl-13-phenyl-15-(prop-1-en-2-yl)-12,14,18-trioxapentacyclo[11.4.1.0¹,¹⁰.0²,⁶.0¹¹,¹⁵]octadecan-8-yl]methyl (2e)-dec-2-enoate
1-(7-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-8-hydroxy-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl)ethanone
6,15'-dihydroxy-7,13'-diisopropyl-1,1,2',4a,6',6'-hexamethyl-2,3,4,10a-tetrahydro-11'-oxaspiro[phenanthrene-9,10'-tetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadecane]-1'(15'),9'(16'),12'-triene-5,8,8',10,14'-pentone
4-[15-hydroxy-11-methoxy-6,6,19,23,23-pentamethyl-26-(2-methylbut-3-en-2-yl)-9,13-dioxo-2,7,24-trioxaheptacyclo[12.12.0.0³,⁸.0³,¹².0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]hexacosa-1(26),14,16(25),17,19,21-hexaen-8-yl]-2-methylbut-2-enoic acid
1β,5α,14α,17α-tetraacetoxy-3β-benzoyloxy-15β-hydroxy-9-oxoparaliane
{"Ingredient_id": "HBIN002372","Ingredient_name": "1\u03b2,5\u03b1,14\u03b1,17\u03b1-tetraacetoxy-3\u03b2-benzoyloxy-15\u03b2-hydroxy-9-oxoparaliane","Alias": "NA","Ingredient_formula": "C35H44O12","Ingredient_Smile": "CC1C(C2C(C3(CC4C(C3(C(C2(C1OC(=O)C)O)OC(=O)C)C)CC(C4=O)(C)C)COC(=O)C)OC(=O)C)OC(=O)C5=CC=CC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21010","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}